MaximilianSchott

Associate

Munich + 49.89.20.60.42.200

Connect:

Share

Maximilian Schott advises industrial corporate clients, financial sponsors, and emerging technology companies on complex domestic and cross-border M&A projects, corporate restructurings, as well as on private equity and venture capital transactions. In addition, Maximilian has significant experience advising on acquisitions, disposals, and refinancing of complex real estate and infrastructure projects. He regularly advises clients across the tech, automotive, energy, chemical, industrial, pharma, and health care industries.

Recently, Maximilian advised, inter alia, Plastic Omnium on its acquisition of OSRAM's automotive lighting business; Sanofi on the carve-out and listing of its API business; SAP on the formation of its financial and insurance services joint venture with DEDIQ (co-investment DEDIQ €500 million); Suez on the sale of its recycling operations to Schwarz Group (€1.1 billion); STERIS on its acquisitions of Cantel Medical ($3.6 billion) and Key Surgical ($850 million); Solvay on the sale of its percarbonate business to Latour Capital; Riverside on its sale of Arrowhead to Genstar; as well as Atlas Arteria on the refinancing of the Warnow tunnel (€157 million).

Prior to joining Jones Day, Maximilian practiced at a boutique law firm in Munich, where he represented, among others, German unicorns Delivery Hero and GetYourGuide on financing rounds and acquisitions.

Maximilian is the founder of the Hans-Jürgen Papier Inn of the International Legal Honor Society of Phi Delta Phi in Munich, a nonprofit organization with more than 200,000 members promoting legal ethics in society around the world. He also serves as province president of Phi Delta Phi in Europe.

Experience

  • LyondellBasell invests in APK, a German plastics recycling companyJones Day represented LyondellBasell as the lead investor in the latest financing round of APK AG, a German plastics recycling company.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Timken acquires GGB Bearing Technology for $305 millionJones Day advised The Timken Company in the $305 million acquisition of GGB Bearing Technology (GGB), a division of Enpro, Industries (including exclusive negotiations with respect to the French operations of GGB).
  • Macquarie acquires Euston Solar FarmJones Day advised Macquarie in the acquisition of 100% of the shares in Euston Solar Farm Limited, a UK-based renewable energy developer focused primarily on the development of utility-scale solar plants.
  • ArchiMed acquires PlasmidFactoryJones Day advised ArchiMed, a leading trans-atlantic private equity healthcare specialist, on its acquisition of PlasmidFactory, a globally renowned high-quality producer of plasmid DNA with strong research capabilities, from IP due diligence to structuring of acquisition and rollover re-investment.
  • Plastic Omnium acquires ams OSRAM Automotive Lighting Systems from ams OSRAM GroupJones Day advised Plastic Omnium in the acquisition of the Automotive Lighting Systems (AMLS) business of ams OSRAM Group in a highly complex international carve-out transaction.
  • Berry Global Inc. completes disposal of Roto-Moulding business to Icelandic investorsJones Day advised Berry Global Inc. in the disposal of plastic rotational moulding business to Rotovia B.V., a special purpose vehicle indirectly owned by Icelandic PE funds, Freyja and Sia IV, and the current management of the business.
  • Macquarie Asset Management acquires 50% shareholding in Island Green PowerJones Day advised Macquarie Asset Management ("MAM"), via Macquarie Green Investment Group Renewable Energy Fund 2 ("MGREF2"), in its acquisition of 50% of the shares in Island Green Power Limited, a UK-based renewable energy developer focused primarily on the development of utility-scale solar plants.
  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Arrowhead Engineered Products acquires Best4ForstJones Day advised Arrowhead Engineered Products, Inc. in the acquisition of Best4Forst, a firm serving the European market with forestry and outdoor power equipment parts ranging from robomowers to commercial logging equipment.
  • Arsenal acquires ATP Group from Bregal UnternehmerkapitalJones Day advised Arsenal Capital Partners in the acquisition of ATP Group, a leading Swiss based manufacturer of water-based adhesive tapes, from Bregal Unternehmerkapital.
  • SAP forms strategic partnership with Dediq for financial services industriesJones Day advised SAP in the formation of SAP Fioneer, a joint venture with the Munich based investor DEDIQ GmbH whereby SAP contributed its Financial Services and Insurance Services business and DEDIQ will invest more than €500 million.
  • Riverside and Investcorp sell Arrowhead Engineered Products to GenstarJones Day advised The Riverside Company in the sale of Arrowhead Engineered Products to Genstar.
  • EMERAM Capital Partners sells portfolio company MEONA to Trill ImpactJones Day represented EMERAM Capital Partners GmbH, one of the leading investment companies for medium-sized companies in the German-speaking region, in the sale of its portfolio company MEONA, an innovation leader for clinical software, to the private equity firm, Trill Impact.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Atlas Arteria establishes new capital structure for Warnow Tunnel in GermanyJones Day advised Atlas Arteria, a global owner, operator, and developer of toll roads, on a new approximately 29-year debt facility for its Warnow Tunnel in Germany as part of a capital restructuring.
  • Solvay sells barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • Wellington Partners, MIG GmbH & Co. Fonds 16, and Salvia GmbH invest €15 million in growth financing of Creative BalloonsJones Day represented Wellington Partners Life Sciences V, a leading European Venture Capital firm investing in early- and growth-stage Life Science companies, together with MIG GmbH & Co. Fonds 16 and Salvia GmbH, in connection with their €15 million growth investment in Creative Balloons GmbH, a specialist in researching and developing ultra-thin polyurethane (PUR) balloons for medical device applications, namely catheter manufacturing.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.